Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ewgenij Proschak

Showing results (21-30 of 183) with videos related to

Pageof 19
Sort By:
Frontiers in Pharmacology|March 29, 2021
Multi-Target Approaches in Metabolic SyndromeFelix F Lillich, John D Imig, Ewgenij Proschak
Chemical Biology & Drug Design|June 20, 2008
Concept of combinatorial de novo design of drug-like molecules by particle swarm optimizationMarkus Hartenfeller, Ewgenij Proschak, Andreas Schüller, et al.
Organic Letters|March 18, 2026
Improved Total Synthesis of Cannabioxepane, a Minor Phytocannabinoid from <i>Cannabis sativa</i> LCornelia H Warmutz, Ewgenij Proschak, Victor Hernandez-Olmos
Cell Cycle (Georgetown, Tex.)|February 9, 2011
Fate of primary cells at the G₁/S boundary after polo-like kinase 1 inhibition by SBE13Sarah Keppner, Ewgenij Proschak, Gisbert Schneider, et al.
Chemmedchem|September 12, 2009
Identification and validation of a potent type II inhibitor of inactive polo-like kinase 1Sarah Keppner, Ewgenij Proschak, Gisbert Schneider, et al.
The Journal of Antimicrobial Chemotherapy|November 30, 2017
Bacterial zincophore [S,S]-ethylenediamine-N,N'-disuccinic acid is an effective inhibitor of MBLsAnna Proschak, Jan Kramer, Ewgenij Proschak, et al.
Proteomics|January 15, 2009
Form follows function: shape analysis of protein cavities for receptor-based drug designMartin Weisel, Ewgenij Proschak, Jan M Kriegl, et al.
Biochemical Pharmacology|October 14, 2018
Two-pronged approach to anti-inflammatory therapy through the modulation of the arachidonic acid cascadeAngelo Sala, Ewgenij Proschak, Dieter Steinhilber, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2017
DrugBank screening revealed alitretinoin and bexarotene as liver X receptor modulatorsPascal Heitel, Janosch Achenbach, Daniel Moser, et al.
Molecular Informatics|July 28, 2016
Automated Docking of Flexible Molecules Into Receptor Binding Sites by Ligand Self-Organization In SituAlexander Klenner, Martin Weisel, Felix Reisen, et al.
Pageof 19

Showing results (21-30 of 183) with videos related to

Sort By:
Pageof 19
Frontiers in Pharmacology|March 29, 2021
Multi-Target Approaches in Metabolic SyndromeFelix F Lillich, John D Imig, Ewgenij Proschak
Chemical Biology & Drug Design|June 20, 2008
Concept of combinatorial de novo design of drug-like molecules by particle swarm optimizationMarkus Hartenfeller, Ewgenij Proschak, Andreas Schüller, et al.
Organic Letters|March 18, 2026
Improved Total Synthesis of Cannabioxepane, a Minor Phytocannabinoid from <i>Cannabis sativa</i> LCornelia H Warmutz, Ewgenij Proschak, Victor Hernandez-Olmos
Cell Cycle (Georgetown, Tex.)|February 9, 2011
Fate of primary cells at the G₁/S boundary after polo-like kinase 1 inhibition by SBE13Sarah Keppner, Ewgenij Proschak, Gisbert Schneider, et al.
Chemmedchem|September 12, 2009
Identification and validation of a potent type II inhibitor of inactive polo-like kinase 1Sarah Keppner, Ewgenij Proschak, Gisbert Schneider, et al.
The Journal of Antimicrobial Chemotherapy|November 30, 2017
Bacterial zincophore [S,S]-ethylenediamine-N,N'-disuccinic acid is an effective inhibitor of MBLsAnna Proschak, Jan Kramer, Ewgenij Proschak, et al.
Proteomics|January 15, 2009
Form follows function: shape analysis of protein cavities for receptor-based drug designMartin Weisel, Ewgenij Proschak, Jan M Kriegl, et al.
Biochemical Pharmacology|October 14, 2018
Two-pronged approach to anti-inflammatory therapy through the modulation of the arachidonic acid cascadeAngelo Sala, Ewgenij Proschak, Dieter Steinhilber, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2017
DrugBank screening revealed alitretinoin and bexarotene as liver X receptor modulatorsPascal Heitel, Janosch Achenbach, Daniel Moser, et al.
Molecular Informatics|July 28, 2016
Automated Docking of Flexible Molecules Into Receptor Binding Sites by Ligand Self-Organization In SituAlexander Klenner, Martin Weisel, Felix Reisen, et al.
Pageof 19